Fair Alecia Malin, Montgomery Kara
Department of Surgery, Meharry Medical College, Nashville, TN, USA.
Methods Mol Biol. 2009;472:57-88. doi: 10.1007/978-1-60327-492-0_3.
This chapter posits that cancer is a complex and multifactorial process as demonstrated by the expression and production of key endocrine and steroid hormones that intermesh with lifestyle factors (physical activity, body size, and diet) in combination to heighten cancer risk. Excess weight has been associated with increased mortality from all cancers combined and for cancers of several specific sites. The prevalence of obesity has reached epidemic levels in many parts of the world; more than 1 billion adults are overweight with a body mass index (BMI) exceeding 25. Overweight and obesity are clinically defined indicators of a disease process characterized by the accumulation of body fat due to an excess of energy intake (nutritional intake) relative to energy expenditure (physical activity). When energy intake exceeds energy expenditure over a prolonged period of time, the result is a positive energy balance (PEB), which leads to the development of obesity. This physical state is ideal for intervention and can be modulated by changes in energy intake, expenditure, or both. Nutritional intake is a modifiable factor in the energy balance-cancer linkage primarily tested by caloric restriction studies in animals and the effect of energy availability. Restriction of calories by 10 to 40% has been shown to decrease cell proliferation, increasing apoptosis through anti-angiogenic processes. The potent anticancer effect of caloric restriction is clear, but caloric restriction alone is not generally considered to be a feasible strategy for cancer prevention in humans. Identification and development of preventive strategies that "mimic" the anticancer effects of low energy intake are desirable. The independent effect of energy intake on cancer risk has been difficult to estimate because body size and physical activity are strong determinants of total energy expenditure. The mechanisms that account for the inhibitory effects of physical activity on the carcinogenic process are reduction in fat stores, activity related changes in sex-hormone levels, altered immune function, effects in insulin and insulin-like growth factors, reduced free radical generation, and direct effect on the tumor. Epidemiologic evidence posits that the cascade of actions linking overweight and obesity to carcinogenesis are triggered by the endocrine and metabolic system. Perturbations to these systems result in the alterations in the levels of bioavailable growth factors, steroid hormones, and inflammatory markers. Elevated serum concentrations of insulin lead to a state of hyperinsulinemia. This physiological state causes a reduction in insulin-like growth factor-binding proteins and promotes the synthesis and biological activity of insulin-like growth factor (IGF)-I, which regulates cellular growth in response to available energy and nutrients from diet and body reserves. In vitro studies have clearly established that both insulin and IGF-I act as growth factors that promote cell proliferation and inhibit apoptosis. Insulin also affects on the synthesis and biological availability of the male and female sex steroids, including androgens, progesterone, and estrogens. Experimental and clinical evidence also indicates a central role of estrogens and progesterone in regulating cellular differentiation, proliferation, and apoptosis induction. Hyperinsulinemia is also associated with alterations in molecular systems such as endogenous hormones and adipokines that regulate inflammatory responses. Obesity-related dysregulation of adipokines has the ability to contribute to tumorigenesis and tumor invasion via metastatic potential. Given the substantial level of weight gain in industrialized countries in the last two decades, there is great interest in understanding all of the mechanisms by which obesity contributes to the carcinogenic process. Continued focus must be directed to understanding the various relationships between specific nutrients and dietary components and cancer cause and prevention. A reductionist approach is not sufficient for the basic biological mechanisms underlying the effect of diet and physical activity on cancer. The joint association between energy balance and cancer risk are hypothesized to share the same underlying mechanisms, the amplification of chemical mediators that modulate cancer risk depending on the responsiveness to those hormones to the target tissue of interest. Disentangling the connection between obesity, the insulin-IGF axis, endogenous hormones, inflammatory markers, and their molecular interaction is vital.
本章认为,癌症是一个复杂的多因素过程,关键内分泌和类固醇激素的表达与产生就证明了这一点,这些激素与生活方式因素(身体活动、体型和饮食)相互交织,共同增加癌症风险。超重与所有癌症合并导致的死亡率增加以及几种特定部位癌症的死亡率增加有关。肥胖症在世界许多地区已达到流行程度;超过10亿成年人超重,体重指数(BMI)超过25。超重和肥胖是一种疾病过程的临床定义指标,其特征是由于能量摄入(营养摄入)相对于能量消耗(身体活动)过多而导致身体脂肪堆积。当能量摄入长期超过能量消耗时,结果就是正能量平衡(PEB),这会导致肥胖症的发展。这种身体状态适合进行干预,可以通过改变能量摄入、消耗或两者来调节。营养摄入是能量平衡与癌症联系中的一个可调节因素,主要通过动物热量限制研究以及能量可利用性的影响来进行测试。将热量摄入限制10%至40%已显示可减少细胞增殖,通过抗血管生成过程增加细胞凋亡。热量限制的强大抗癌作用是明确的,但仅热量限制一般不被认为是人类预防癌症的可行策略。识别和开发“模拟”低能量摄入抗癌作用的预防策略是可取的。能量摄入对癌症风险的独立影响一直难以估计,因为体型和身体活动是总能量消耗的重要决定因素。身体活动对致癌过程的抑制作用机制包括脂肪储存减少、与活动相关的性激素水平变化、免疫功能改变、对胰岛素和胰岛素样生长因子的影响、自由基生成减少以及对肿瘤的直接作用。流行病学证据表明,将超重和肥胖与致癌作用联系起来的一系列行动是由内分泌和代谢系统触发的。这些系统的紊乱会导致生物可利用生长因子、类固醇激素和炎症标志物水平的改变。血清胰岛素浓度升高会导致高胰岛素血症状态。这种生理状态会导致胰岛素样生长因子结合蛋白减少,并促进胰岛素样生长因子(IGF)-I的合成和生物活性,IGF-I会根据饮食和身体储备中可用的能量和营养来调节细胞生长。体外研究已明确证实,胰岛素和IGF-I均作为促进细胞增殖和抑制细胞凋亡的生长因子起作用。胰岛素还会影响男性和女性类固醇激素(包括雄激素、孕酮和雌激素)的合成和生物可利用性。实验和临床证据还表明,雌激素和孕酮在调节细胞分化、增殖和诱导细胞凋亡方面起着核心作用。高胰岛素血症还与调节炎症反应的内源性激素和脂肪因子等分子系统的改变有关。肥胖相关的脂肪因子失调有能力通过转移潜能促进肿瘤发生和肿瘤侵袭。鉴于过去二十年工业化国家体重增加的幅度很大,人们对了解肥胖导致致癌过程的所有机制非常感兴趣。必须持续关注了解特定营养素和饮食成分与癌症病因及预防之间的各种关系。一种简化论方法不足以解释饮食和身体活动对癌症影响的基本生物学机制。能量平衡与癌症风险之间的联合关联被假设具有相同的潜在机制,即化学介质的放大作用,这些介质根据对感兴趣的靶组织中那些激素的反应性来调节癌症风险。理清肥胖、胰岛素-IGF轴、内源性激素、炎症标志物及其分子相互作用之间的联系至关重要。